Medical Unit Clinical Nutrition, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Division of Hepatology, Department of Upper Gastrointestinal Diseases and Surgical Oncology, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Nutrition. 2023 Jun;110:111982. doi: 10.1016/j.nut.2023.111982. Epub 2023 Feb 2.
Dietary composition may affect body composition during weight loss therapy. We tested the hypothesis of whether dietary macronutrient composition influences the reduction of total abdominal adipose tissue, subcutaneous adipose tissue (SAT), or visceral adipose tissue (VAT) during weight loss.
Dietary macronutrient composition and body composition were analyzed as a secondary outcome of a randomized controlled trial of 62 participants with non-alcoholic fatty liver disease. Patients were randomly assigned to a calorie-restricted intermittent fasting (5:2), calorie-restricted low-carbohydrate high-fat (LCHF), or healthy lifestyle advice (standard-of-care) diet in a 12-wk intervention phase. Dietary intake was assessed by self-reported 3-d food diaries and by characterization of total plasma fatty acid profile. Percentage of energy intake (E%) from different macronutrients was calculated. Body composition was assessed by magnetic resonance imaging and anthropometric measurements.
The macronutrient composition differed significantly between the 5:2 (fat 36 E% and carbohydrates 43 E%) and the LCHF (fat 69 E% and carbohydrates 9 E%) groups (P < 0.001). Weight loss was similar in the 5:2 and LCHF groups (-7.2 [SD = 3.4] kg versus 8.0 [SD = 4.8] kg; P = 0.44) and significantly larger than for standard of care (-2.5 kg [SD = 2.3]; P < 0.001). The volume of total abdominal fat, adjusted for height, decreased on average by 4.7% (standard of care), 14.3% (5:2), and 17.7% (LCHF), with no significant differences between the 5:2 and LHCF groups (P = 0.32). VAT and SAT, adjusted for height, decreased on average by 17.1% and 12.7% for 5:2, respectively, and by 21.2% and 17.9% for LCHF, with no significant group differences (VAT [P = 0.16] and SAT [P = 0.10]). VAT was mobilized to a greater extent than SAT in all diets.
The 5:2 and LCHF diets had similar effects on changes in intraabdominal fat mass and anthropometrics during weight loss. This might indicate that overall weight loss is more important than diet composition to achieve changes in total abdominal adipose tissue, VAT, or SAT. The results of the present study suggest that there is a need for further studies on the effect of diet composition on body composition changes during weight loss therapy.
饮食成分可能会影响减肥治疗过程中的身体成分。我们检验了这样一个假设,即饮食宏量营养素组成是否会影响减肥过程中总腹部脂肪、皮下脂肪(SAT)或内脏脂肪(VAT)的减少。
对 62 名非酒精性脂肪性肝病患者进行的随机对照试验的次要结果分析了饮食宏量营养素组成和身体成分。患者被随机分配到热量限制间歇性禁食(5:2)、热量限制低碳水化合物高脂肪(LCHF)或健康生活方式建议(标准护理)饮食的 12 周干预阶段。通过自我报告的 3 天食物日记和总血浆脂肪酸谱的特征来评估饮食摄入。计算不同宏量营养素的能量摄入百分比(E%)。通过磁共振成像和人体测量评估身体成分。
5:2(脂肪 36 E%,碳水化合物 43 E%)和 LCHF(脂肪 69 E%,碳水化合物 9 E%)组之间的宏量营养素组成差异显著(P < 0.001)。5:2 组和 LCHF 组的体重减轻相似(分别为-7.2 [SD=3.4] kg 和 8.0 [SD=4.8] kg;P=0.44),且明显大于标准护理组(-2.5 kg [SD=2.3];P < 0.001)。调整身高后,总腹部脂肪体积平均减少 4.7%(标准护理)、14.3%(5:2)和 17.7%(LCHF),5:2 和 LHCF 组之间无显著差异(P=0.32)。调整身高后,5:2 组的 VAT 和 SAT 分别减少 17.1%和 12.7%,LCHF 组分别减少 21.2%和 17.9%,各组间无显著差异(VAT [P=0.16]和 SAT [P=0.10])。在所有饮食中,VAT 的动员程度都大于 SAT。
5:2 和 LCHF 饮食在减肥期间对腹部脂肪质量和人体测量学的变化有相似的影响。这可能表明,总体体重减轻比饮食组成对总腹部脂肪、VAT 或 SAT 的变化更为重要。本研究结果表明,有必要进一步研究饮食组成对减肥治疗期间身体成分变化的影响。